Minimal Invasive Retrieval of Dislodged Amplatzer Occluder with Subsequent Impediments

Philipp Born; Friedrich Eckstein; Peter Buser; Oliver Reuthebuch

doi:10.1055/s-0032-1304551

The Thoracic and Cardiovascular Surgeon, Table of Contents

Thorac Cardiovasc Surg 2013; 61(04): 330-332
DOI: 10.1055/s-0032-1304551

Case Report

Georg Thieme Verlag KG Stuttgart · New York

Minimal Invasive Retrieval of Dislodged Amplatzer Occluder with Subsequent Impediments

Philipp Born

¹Department of Cardiac Surgery, University Hospital Basel, Basel, Switzerland

,

Friedrich Eckstein

¹Department of Cardiac Surgery, University Hospital Basel, Basel, Switzerland

,

Peter Buser

²Department of Cardiology, University Hospital Basel, Basel, Switzerland

,

Oliver Reuthebuch

¹Department of Cardiac Surgery, University Hospital Basel, Basel, Switzerland

› Author Affiliations

Abstract

All articles of this category

Abstract

A 47-year-old female underwent interventional patent foramen ovale (PFO) closure with an Amplatzer septal occluder (AGA Medical Corporation, USA). After 48 hours of implantation, she experienced intermittent pulse synchronous retrosternal pain. Subsequently, device-associated compression of the aortic root was diagnosed. Occluder retrieval and surgical PFO-closure was accomplished successfully via minimal invasive, video-assisted anterolateral thoracotomy.

Keywords

patent foramen ovale - septal occluder - aorta - anterolateral thoracotomy

Full Text

References

References
1 El-Said HG, Moore JW. Erosion by the Amplatzer septal occluder: experienced operator opinions at odds with manufacturer recommendations?. Catheter Cardiovasc Interv 2009; 73 (7) 925-930
2 Amin Z, Hijazi ZM, Bass JL, Cheatham JP, Hellenbrand WE, Kleinman CS. Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc Interv 2004; 63 (4) 496-502
3 DiBardino DJ, McElhinney DB, Kaza AK, Mayer Jr JE. Analysis of the US Food and Drug Administration Manufacturer and User Facility Device Experience database for adverse events involving Amplatzer septal occluder devices and comparison with the Society of Thoracic Surgery congenital cardiac surgery database. J Thorac Cardiovasc Surg 2009; 137 (6) 1334-1341
4 Chun DS, Turrentine MW, Moustapha A, Hoyer MH. Development of aorta-to-right atrial fistula following closure of secundum atrial septal defect using the Amplatzer septal occluder. Catheter Cardiovasc Interv 2003; 58 (2) 246-251
5 Lopez-Fernandez T , et al. Aortic wall erosion after percutaneous closure of atrial septal defect. J Am Soc Echocardiogr 2011; 24 (2) 227
6 Ivens E, Hamilton-Craig C, Aroney C, Clarke A, Jalali H, Burstow DJ. Early and late cardiac perforation by Amplatzer atrial septal defect and patent foramen ovale devices. J Am Soc Echocardiogr 2009; 22 (9) 1067-1070
7 Baykut D, Doerge SE, Grapow M, Bremerich J, Zerkowski HR. Late perforation of the aortic root by an atrial septal defect occlusion device. Ann Thorac Surg 2005; 79 (3) e28
8 Divekar A, Gaamangwe T, Shaikh N, Raabe M, Ducas J. Cardiac perforation after device closure of atrial septal defects with the Amplatzer septal occluder. J Am Coll Cardiol 2005; 45 (8) 1213-1218
9 Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia and cardiac surgery. Ann Thorac Surg 2003; 76 (2) 638-648